Back to Search
Start Over
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy
- Source :
- Communications Medicine, Vol 2, Iss 1, Pp 1-10 (2022)
- Publication Year :
- 2022
- Publisher :
- Nature Portfolio, 2022.
-
Abstract
- Knight et al. assess short-term patient-reported outcomes (PROs) and markers of neurotoxicity in patients with leukaemia or lymphoma treated with LV20.19 CAR T cells. In this small trial cohort, the authors report improvements in mood following CAR T infusion and identify kynurenine pathway molecules as potential markers of mood and neurotoxicity.
- Subjects :
- Medicine
Subjects
Details
- Language :
- English
- ISSN :
- 2730664X
- Volume :
- 2
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Communications Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.56255e90ea724f659420f005396f9009
- Document Type :
- article
- Full Text :
- https://doi.org/10.1038/s43856-022-00116-5